Brief: Kura Oncology And Kyowa Kirin Announce Strategic Collaboration To Develop And Commercialize Ziftomenib In Acute Leukemias

Kura Oncology

20/11/2024 22:02

Nov 20 (Reuters) - Kyowa Kirin Co Ltd  4151.T :
    * KURA ONCOLOGY AND KYOWA KIRIN ANNOUNCE GLOBAL STRATEGIC
COLLABORATION TO DEVELOP AND COMMERCIALIZE ZIFTOMENIB IN ACUTE
LEUKEMIAS
    * KURA ONCOLOGY INC - TO RECEIVE $330 MILLION UPFRONT, UP TO
$1.2
BILLION IN MILESTONES
    * KURA ONCOLOGY INC - TO INITIATE PHASE 3 FRONTLINE STUDIES
IN AML
IN 2025

Source text:  ID:nGNX7fjytx 
Further company coverage:  4151.T